<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-07T23:04:31Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/7557" metadataPrefix="rdf">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/7557</identifier><datestamp>2023-04-18T12:38:02Z</datestamp><setSpec>com_10259_4862</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4863</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication rdf:about="oai:riubu.ubu.es:10259/7557">
<dc:title>Bacteriophages as Biotechnological Tools</dc:title>
<dc:creator>Alves Elois, Mariana</dc:creator>
<dc:creator>Silva, Raphael da</dc:creator>
<dc:creator>Pilati, Giulia</dc:creator>
<dc:creator>Rodríguez Lázaro, David</dc:creator>
<dc:creator>Fongaro, Gislaine</dc:creator>
<dc:subject>Bacteriophages</dc:subject>
<dc:subject>Applications</dc:subject>
<dc:subject>Biotechnological</dc:subject>
<dc:description>Bacteriophages are ubiquitous organisms that can be specific to one or multiple strains&#xd;
of hosts, in addition to being the most abundant entities on the planet. It is estimated that they&#xd;
exceed ten times the total number of bacteria. They are classified as temperate, which means that&#xd;
phages can integrate their genome into the host genome, originating a prophage that replicates&#xd;
with the host cell and may confer immunity against infection by the same type of phage; and lytics,&#xd;
those with greater biotechnological interest and are viruses that lyse the host cell at the end of its&#xd;
reproductive cycle. When lysogenic, they are capable of disseminating bacterial antibiotic resistance&#xd;
genes through horizontal gene transfer. When professionally lytic—that is, obligately lytic and not&#xd;
recently descended from a temperate ancestor—they become allies in bacterial control in ecological&#xd;
imbalance scenarios; these viruses have a biofilm-reducing capacity. Phage therapy has also been&#xd;
advocated by the scientific community, given the uniqueness of issues related to the control of&#xd;
microorganisms and biofilm production when compared to other commonly used techniques. The&#xd;
advantages of using bacteriophages appear as a viable and promising alternative. This review will&#xd;
provide updates on the landscape of phage applications for the biocontrol of pathogens in industrial&#xd;
settings and healthcare.</dc:description>
<dc:date>2023-03-20T08:25:19Z</dc:date>
<dc:date>2023-03-20T08:25:19Z</dc:date>
<dc:date>2023-01</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>http://hdl.handle.net/10259/7557</dc:identifier>
<dc:identifier>10.3390/v15020349</dc:identifier>
<dc:identifier>1999-4915</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Viruses. 2023, V. 15, n. 2, 349</dc:relation>
<dc:relation>https://doi.org/10.3390/v15020349</dc:relation>
<dc:relation>info:eu-repo/grantAgreement/UFSC//201917940/BR/</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:publisher>MDPI</dc:publisher>
</ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>